SC 13G: REVIVA PHARMACEUTICALS HOLDINGS, INC.

AI Summary

SC 13G filing by REVIVA PHARMACEUTICALS HOLDINGS, INC..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securitie

Filing Documents

• e664026_sc13g-rph.htm (SC 13G) — 54KB
• 0001193805-24-001374.txt ( ) — 55KB

(a)

Item 1(a). Name of Issuer: Reviva Pharmaceuticals Holdings, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 10080 N. Wolfe Road, Suite SW3-200 Cupertino, CA 95014

(a)

Item 2(a). Name of Person Filing: Schonfeld Strategic Advisors LLC (“ Schonfeld ”) is an investment adviser to several private funds. Schonfeld also engages third party sub-advisers to manage assets of its private funds as separately managed accounts (the “ Schonfeld SMAs ”). Accordingly, Schonfeld may be deemed to indirectly beneficially own securities owned by the Schonfeld SMAs. Each Schonfeld SMA is the record and direct beneficial herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934 or any other purpose, the beneficial owner of any securities covered by this statement.

(b)

Item 2(b). Address of Principal Business Office, or if None, Residence: 590 Madison Avenue, 23rd Floor, New York, New York 10022

(c)

Item 2(c). Citizenship: Delaware limited liability company

(d)

Item 2(d). Title of Class of Securities: Common Stock, par value $0.0001 per share

(e)

Item 2(e). CUSIP Number: 76152G100 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act. (b) Bank as defined in Section 3(a)(6) of the Exchange Act. (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act. CUSIP No. 76152G100 13G Page 4 of 7 Pages (d) Investment company registered under Section 8 of the Investment Company Act. (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: __________________________________________

Ownership

Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,772,715 shares (b) Percent of class: 5.30% (c) Number of shares as to which such person has**: (i) Sole power to vote or to direct the vote 1,515,900 shares (ii) Shared power to vote or to direct the vote 256,815 shares (iii) Sole power to dispose or to direct the disposition of 1,515,900 shares (iv) Shared power to dispose or to direct the disposition of 256,815 shares CUSIP No. 76152G100 13G Page 5 of 7 Pages Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following . Item 6. of Another Person. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The securities held by each of the Schonfeld SMAs as to which this statement is filed are owned of record by clients of Schonfeld. Those clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, such securities. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. If a parent holding company or Control per